MBTPS1 and stroke disorder: Results from the study of both MS and stroke support S1P receptor-mediated signaling as relevant to these diseases through effects not only on neuroinflammation but also through direct CNS effects involving neuroglial activity, with particular relevance to recurrent stroke through the ability of locally microinjected S1P to potentiate M/R stroke damage.